Details

NameSymbolSector
SAMRAT PHARMACHEM LTD.SAMRATPHPharmaceuticals
Open
214.95
High
214.95
Low
205
Close
211.5
Volume
1720
Exchange
bse
Time
28-Apr-2026

Outlook

Score:  

1.25

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Samrat Pharmachem is  
None
Estimated Stoploss of Samrat Pharmachem is ₹  
214.95
Samrat Pharmachem has a  
Bearishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Samrat Pharmachem is  
Unpredictableℹ
. 

Trend

Samrat Pharmachem is in  
Sideways trendℹ
. 
Price of Samrat Pharmachem is  
Upℹ
 by  

0.15

%. 
Target
Buy @ 

188.63

Sell @ 

235.07

Current @ 

211.5

Volume

The trade volumes of Samrat Pharmachem have become  
Deficientℹ
Though the volume trend for Samrat Pharmachem appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Samrat Pharmachem is  

Down

 by  

16.48

% 

Valuation

The current market price of Samrat Pharmachem is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 121cr and total assets worth ₹ 121cr, the balance sheet of Samrat Pharmachem is:  
Balancedℹ
. 
Cashflow
Samrat Pharmachem has  
Badℹ
 cash flow because there is  

Shortage

 of  

₹ 9cr

. It is  
Downℹ
 by  

350

%. 

(*Mar 2025)

100% i.e. ₹ 10cr spent in operatingℹ
0% in investingℹ
0% in financingℹ
0% in otherℹ
Samrat Pharmachem has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 2cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

45% i.e. ₹ 9cr earned in operatingℹ
0% in investingℹ
55% i.e. ₹ 11cr spent in financingℹ
0% in otherℹ
Income
The income of Samrat Pharmachem is  

₹ 78cr

 and  

Loss

 is :  

₹ 0cr

(*Sep 2025)

Samrat Pharmachem Losses increased by:  

0

% and Income is Up by:  

2.63

% 

(*Sep 2025)

The income of Samrat Pharmachem is  

₹ 76cr

 and  

Loss

 is :  

₹ 0cr

(*Jun 2025)

Samrat Pharmachem Losses increased by:  

0

% and Income is Up by:  

7.04

% 

(*Jun 2025)

The income of Samrat Pharmachem is  

₹ 71cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Samrat Pharmachem Losses increased by:  

100

% and Income is Up by:  

12.7

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.